Health Canada has lifted the suspension of a flu vaccine that accounts for 30 per cent of the Novartis brand vaccine. The federal health department had suspended use of all Novartis influenza vaccines after two of the seasonal flu vaccines produced by Novartis were pulled from use in several European countries. In a release the government agency said, “Health Canada looked at the results of its own testing, conducted a health risk assessment, and reviewed information from its European partners and data submitted by Novartis in making its decision. None of the information reviewed indicated a safety issue.”
